Targeting the dna damage response for anti-cancer therapy

Éditeur : Springer International Publishing AG
ISBN : 9783319758343
Date de publication : 5 juin 2018
Dimensions : 23,5 x 15,5 cm
Langue : Anglais
Pays d'origine : Suisse

As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents thatmay have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.

265,49 €
Prix de vente belge indicatif
Disponibilité
Print on Demand

Pour commander, veuillez vous connecter à votre compte.